MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 56 filers reported holding MEDIVATION INC in Q3 2016. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,794,000 | +161.1% | 46,350 | +99.1% | 0.02% | +21.4% |
| Q1 2016 | $1,070,000 | -73.1% | 23,275 | -71.8% | 0.01% | -74.1% |
| Q4 2015 | $3,983,000 | +4.2% | 82,400 | -8.3% | 0.05% | +5.9% |
| Q3 2015 | $3,821,000 | -33.4% | 89,900 | +79.0% | 0.05% | -25.0% |
| Q2 2015 | $5,735,000 | -10.3% | 50,215 | +1.4% | 0.07% | -9.3% |
| Q1 2015 | $6,394,000 | +52.4% | 49,540 | +17.6% | 0.08% | +66.7% |
| Q4 2014 | $4,195,000 | -2.9% | 42,115 | -3.6% | 0.04% | -6.2% |
| Q3 2014 | $4,320,000 | +21.2% | 43,690 | -5.5% | 0.05% | +37.1% |
| Q2 2014 | $3,564,000 | +10.7% | 46,240 | -7.5% | 0.04% | -16.7% |
| Q1 2014 | $3,219,000 | +66.1% | 50,015 | +64.7% | 0.04% | +61.5% |
| Q4 2013 | $1,938,000 | +8.8% | 30,360 | +2.2% | 0.03% | +18.2% |
| Q3 2013 | $1,781,000 | +4.0% | 29,710 | -14.7% | 0.02% | -4.3% |
| Q2 2013 | $1,713,000 | – | 34,810 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |